Accelerating Progress in Human Health and Scientific Research

At Parse Biosciences, we are providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease. Single cell RNA sequencing has already enabled breakthroughs in developmental biology, stem cell therapy, immunotherapy, and cancer treatments. Our foundational Evercode™ combinatorial barcoding technology is driving the next generation of discoveries.

Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research.

The People of Parse

The people of Parse are curious, collaborative, and driven by purpose.

Upcoming Events

American Association for Cancer Research (AACR) Annual Meeting

Apr 14   -   Apr 19

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. Stop by booth #1202 to learn more about our Evercode TCR platform.

More Information

EMBL Symposium - Brain Genome: Regulation, Evolution, and Function

Apr 25   -   Apr 28

Parse Biosciences team members will be on hand to share information about our technology and products at this symposium that explores how the genome is regulated in the brain to support neural function and plasticity.

More Information

Danish Single Cell Conference

Apr 26   -   Apr 27

Parse Biosciences is happy to be a sponsor of this conference which will focus on novel wet-lab and computational approaches in single cell omics field to investigate the function of complex tissues in health and disease. Our team members will be on hand to share information about the Evercode product line and technology.

More Information